Trends in the Treatment of Partial Thickness Venous Leg Ulcers (n=286)

In a recent micro survey designed by Michel H.E. Hermans, MD, Medical Director, 3S Consulting Group, Inc. and featured within the WOC Skin Health Weekly® digital publication, respondents were asked to report on the treatment of partial thickness venous leg ulcers.

For this study, partial Thickness Venous Leg Ulcers were defined as superficial (venous) ulcerations with low to moderate drainage. From the collected data the following trends could be observed:

Approximately 94% of respondents reported that they routinely treat Partial Thickness Venous Leg Ulcers.

Of those that do, 52% described their clinical certification as Would Ostomy Continence Nurse. The average number of years of experience in treating Partial Thickness Venous Leg Ulcers ranged between 5-10 years.

The Hospital (34%) was the clinical setting in which Partial Thickness Venous Leg Ulcers were treated most often, followed closely by Wound Clinic (33%), and Long Term Care (13%).

When debridement was indicated, Enzymatic debridement was most often selected (42%) for Partial Thickness Venous Leg Ulcers, followed by Autolytic (29%), and Sharps surgical debridement (20%).

Those who selected Enzymatic debridement reported the reason for their selection as “Small amount of necrosis/slough” (26%), “Minimal trauma to healthy tissue” (23%), and “Minimal disturbance to the wound and Peri-wound tissue” (22%).

Those who selected Autolytic debridement reported the reason for selection as “Small amount of necrosis/slough” (25%) and “Minimal disturbance to the wound and Peri-wound tissue” (24%).

Those who selected Sharps debridement reported the reason for selection as “Need for rapid debridement” (41%) and “Large amount of necrosis/slough” (23%).

Alginates/Hydrofibers (20%) were utilized most often as the primary wound dressing for the management of Partial Thickness Venous Leg Ulcers (“Primary” was defined as the dressing which was applied directly to the wound bed).

Those who selected Alginates/Hydrofibers as the primary dressing reported the reason for selection as “Amount of exudate absorbed” (65%), “Positive patient outcomes” (15%), and “Manner in which exudate is absorbed (horizontal/vertical wicking)” (7%).

Those who selected Foams (excluding silver containing foams) as the primary dressing reported the reason for selection as “Amount of exudate absorbed” (38%), “Ease pain associated with dressing changes” (15%), “Prevent peri-wound skin maceration” (12%), and “Manner in which exudate is absorbed” (12%).

Those who selected Silver Dressings as the primary dressing reported the reason for selection as “Decrease in bioburden/biofilm” (66%), “Positive patient outcomes” (9%), and “Ease pain associated with dressing changes” (6%).

Please contact your 3S Account Executive if you are interested in more in-depth research on Trends in the Treatment of Venous Leg Ulcers.